VERTEX PHARMACEUTICALS INC / MA Operating Cash Flow 2008-2025 | VRTX
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is VERTEX PHARMACEUTICALS INC / MA's current operating cash flow?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual operating cash flow for 2025 was $3.63B, a 837.19% increase from 2024. VERTEX PHARMACEUTICALS INC / MA operating cash flow for the quarter ending December 31, 2025 was $498.0M.
What was VERTEX PHARMACEUTICALS INC / MA's operating cash flow in 2024?
VERTEX PHARMACEUTICALS INC / MA annual operating cash flow for 2024 was $-492.6M, a 113.93% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's operating cash flow in 2023?
VERTEX PHARMACEUTICALS INC / MA annual operating cash flow for 2023 was $3.54B, a 14.35% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year operating cash flow CAGR?
VERTEX PHARMACEUTICALS INC / MA operating cash flow grew at a compound annual growth rate (CAGR) of 2.22% from FY2020 to FY2025, going from $3.25B to $3.63B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.63B | +837.2% | 10-K |
| FY2024 | $-492.6M | -113.9% | 10-K |
| FY2023 | $3.54B | -14.3% | 10-K |
| FY2022 | $4.13B | +56.2% | 10-K |
| FY2021 | $2.64B | -18.7% | 10-K |
| FY2020 | $3.25B | +107.3% | 10-K |
| FY2019 | $1.57B | +23.5% | 10-K |
| FY2018 | $1.27B | +50.3% | 10-K |
| FY2017 | $844.9M | +257.9% | 10-K |
| FY2016 | $236.1M | +164.6% | 10-K |
| FY2015 | $-365.4M | +36.2% | 10-K |
| FY2014 | $-573.1M | -844.7% | 10-K |
| FY2013 | $-60.7M | -122.7% | 10-K |
| FY2012 | $267.8M | +86.3% | 10-K |
| FY2011 | $143.7M | +122.6% | 10-K |
| FY2010 | $-635.4M | -48.6% | 10-K |
| FY2009 | $-427.6M | -88.8% | 10-K |
| FY2008 | $-226.5M | - | 10-K |